232 related articles for article (PubMed ID: 35011711)
21. Antioxidant function of phytocannabinoids: Molecular basis of their stability and cytoprotective properties under UV-irradiation.
Vacek J; Vostalova J; Papouskova B; Skarupova D; Kos M; Kabelac M; Storch J
Free Radic Biol Med; 2021 Feb; 164():258-270. PubMed ID: 33453360
[TBL] [Abstract][Full Text] [Related]
22. Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma.
Lah TT; Novak M; Pena Almidon MA; Marinelli O; Žvar Baškovič B; Majc B; Mlinar M; Bošnjak R; Breznik B; Zomer R; Nabissi M
Cells; 2021 Feb; 10(2):. PubMed ID: 33562819
[TBL] [Abstract][Full Text] [Related]
23. Effects of the lysosomal destabilizing drug siramesine on glioblastoma in vitro and in vivo.
Jensen SS; Petterson SA; Halle B; Aaberg-Jessen C; Kristensen BW
BMC Cancer; 2017 Mar; 17(1):178. PubMed ID: 28270132
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2.
McHugh D; Tanner C; Mechoulam R; Pertwee RG; Ross RA
Mol Pharmacol; 2008 Feb; 73(2):441-50. PubMed ID: 17965195
[TBL] [Abstract][Full Text] [Related]
25. Astrocytes Decreased the Sensitivity of Glioblastoma Cells to Temozolomide and Bay 11-7082.
Pustchi SE; Avci NG; Akay YM; Akay M
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998285
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of cannabinoids against glioblastoma multiforme: A systematic review.
Kyriakou I; Yarandi N; Polycarpou E
Phytomedicine; 2021 Jul; 88():153533. PubMed ID: 33812759
[TBL] [Abstract][Full Text] [Related]
27. Glial activation in the early stages of brain metastasis: TSPO as a diagnostic biomarker.
O'Brien ER; Kersemans V; Tredwell M; Checa B; Serres S; Soto MS; Gouverneur V; Leppert D; Anthony DC; Sibson NR
J Nucl Med; 2014 Feb; 55(2):275-80. PubMed ID: 24434290
[TBL] [Abstract][Full Text] [Related]
28. Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol.
Gomes FV; Llorente R; Del Bel EA; Viveros MP; López-Gallardo M; Guimarães FS
Schizophr Res; 2015 May; 164(1-3):155-63. PubMed ID: 25680767
[TBL] [Abstract][Full Text] [Related]
29. Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review.
Dos Santos RG; Hallak JEC; Crippa JAS
Adv Exp Med Biol; 2021; 1264():29-45. PubMed ID: 33332002
[TBL] [Abstract][Full Text] [Related]
30. Cannabinoids and glial cells: possible mechanism to understand schizophrenia.
de Almeida V; Martins-de-Souza D
Eur Arch Psychiatry Clin Neurosci; 2018 Oct; 268(7):727-737. PubMed ID: 29392440
[TBL] [Abstract][Full Text] [Related]
31. Differential effects of cannabis extracts and pure plant cannabinoids on hippocampal neurones and glia.
Ryan D; Drysdale AJ; Pertwee RG; Platt B
Neurosci Lett; 2006 Nov; 408(3):236-41. PubMed ID: 16997463
[TBL] [Abstract][Full Text] [Related]
32. Delta-9-tetrahydrocannabinol accumulation, metabolism and cell-type-specific adverse effects in aggregating brain cell cultures.
Monnet-Tschudi F; Hazekamp A; Perret N; Zurich MG; Mangin P; Giroud C; Honegger P
Toxicol Appl Pharmacol; 2008 Apr; 228(1):8-16. PubMed ID: 18083204
[TBL] [Abstract][Full Text] [Related]
33. The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis.
Jamontt JM; Molleman A; Pertwee RG; Parsons ME
Br J Pharmacol; 2010 Jun; 160(3):712-23. PubMed ID: 20590574
[TBL] [Abstract][Full Text] [Related]
34. Nanotherapeutic Modulation of Human Neural Cells and Glioblastoma in Organoids and Monocultures.
Zhang I; Lépine P; Han C; Lacalle-Aurioles M; Chen CX; Haag R; Durcan TM; Maysinger D
Cells; 2020 Nov; 9(11):. PubMed ID: 33171886
[TBL] [Abstract][Full Text] [Related]
35. Cannabinoid effects on β amyloid fibril and aggregate formation, neuronal and microglial-activated neurotoxicity in vitro.
Janefjord E; Mååg JL; Harvey BS; Smid SD
Cell Mol Neurobiol; 2014 Jan; 34(1):31-42. PubMed ID: 24030360
[TBL] [Abstract][Full Text] [Related]
36. Differential Interactions of Selected Phytocannabinoids with Human CYP2D6 Polymorphisms.
Huff HC; Vasan A; Roy P; Kaul A; Tajkhorshid E; Das A
Biochemistry; 2021 Sep; 60(37):2749-2760. PubMed ID: 34491040
[TBL] [Abstract][Full Text] [Related]
37. Melanoma spheroids grown under neural crest cell conditions are highly plastic migratory/invasive tumor cells endowed with immunomodulator function.
Ramgolam K; Lauriol J; Lalou C; Lauden L; Michel L; de la Grange P; Khatib AM; Aoudjit F; Charron D; Alcaide-Loridan C; Al-Daccak R
PLoS One; 2011 Apr; 6(4):e18784. PubMed ID: 21526207
[TBL] [Abstract][Full Text] [Related]
38. The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.
McAllister SD; Soroceanu L; Desprez PY
J Neuroimmune Pharmacol; 2015 Jun; 10(2):255-67. PubMed ID: 25916739
[TBL] [Abstract][Full Text] [Related]
39. Unveiling the mechanism of action behind the anti-cancer properties of cannabinoids in ER
Amaral C; Trouille FM; Almeida CF; Correia-da-Silva G; Teixeira N
J Steroid Biochem Mol Biol; 2021 Jun; 210():105876. PubMed ID: 33722705
[TBL] [Abstract][Full Text] [Related]
40. Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model.
Mitchell VA; Harley J; Casey SL; Vaughan AC; Winters BL; Vaughan CW
Neuropharmacology; 2021 May; 189():108529. PubMed ID: 33741405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
